Metastatic Triple-Negative Breast Cancer (MTNBC) Market to Witness increasing Investment in R&D owing to Rising Disease Prevalence
Metastatic triple-negative breast cancer (MTNBC) refers to an aggressive form of breast cancer that does not express estrogen receptors, progesterone receptors, or high levels of human epidermal growth factor receptor 2 (HER2). MTNBC treatment has been particularly challenging due to the lack of specific drug targets. Currently, chemotherapy remains the primary treatment option, however,...
0 Commenti 0 condivisioni 329 Views 0 Anteprima